Sarah Laing

Sarah Laing

Auto-generated profile, based on publicly available information

Sarah Laing

School of Cancer Sciences, University of Glasgow, Glasgow, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
NMNathiya Muthalagu
Nathiya Muthalagu
TMTiziana Monteverde
Tiziana Monteverde
XRXimena Raffo-Iraolagoitia
Ximena Raffo-Iraolagoitia
RWRobert Wiesheu
Robert Wiesheu
DWDeclan Whyte
Declan Whyte
Daniel J. MurphyDaniel J. Murphy
Daniel J. Murphy
MYC is implicated in the development and progression of pancreatic cancer, yet the precise level of MYC deregulation required to contribute to tumor development has been difficult to define. We used modestly elevated expression of human MYC, driven from the Rosa26 locus, to investigate the pancreatic phenotypes arising in mice from an approximation of MYC trisomy. We show that this level of MYC alone suffices to drive pancreatic neuroendocrine tumors, and to accelerate progression of KRAS-initiated precursor lesions to metastatic pancreatic ductal adenocarcinoma (PDAC). Our phenotype exposed suppression of the type I interferon (IFN) pathway by the combined actions of MYC and KRAS, and we present evidence of repressive MYC–MIZ1 complexes binding directly to the promoters of the genes encodiing the type I IFN regulators IRF5, IRF7, STAT1, and STAT2. Derepression of IFN regulator genes allows pancreatic tumor infiltration by B and natural killer (NK) cells, resulting in increased survival. Significance: We define herein a novel mechanism of evasion of NK cell–mediated immunity through the combined actions of endogenously expressed mutant KRAS and modestly deregulated expression of MYC, via suppression of the type I IFN pathway. Restoration of IFN signaling may improve outcomes for patients with PDAC. This article is highlighted in the In This Issue feature, p. 747

20 June 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
BKBjörn Kruspig
Björn Kruspig
TMTiziana Monteverde
Tiziana Monteverde
SNSarah Neidler
Sarah Neidler
AHAndreas Hock
Andreas Hock
EKEmma Kerr
Emma Kerr
Daniel J. MurphyDaniel J. Murphy
Daniel J. Murphy
KRAS is the most frequently mutated driver oncogene in human adenocarcinoma of the lung. There are presently no clinically proven strategies for treatment of KRAS-driven lung cancer. Activating mutations in KRAS are thought to confer independence from upstream signaling; however, recent data suggest that this independence may not be absolute. We show that initiation and progression of KRAS-driven lung tumors require input from ERBB family receptor tyrosine kinases (RTKs): Multiple ERBB RTKs are expressed and active from the earliest stages of KRAS-driven lung tumor development, and treatment with a multi-ERBB inhibitor suppresses formation of KRASG12D-driven lung tumors. We present evidence that ERBB activity amplifies signaling through the core RAS pathway, supporting proliferation of KRAS-mutant tumor cells in culture and progression to invasive disease in vivo. Brief pharmacological inhibition of the ERBB network enhances the therapeutic benefit of MEK (mitogen-activated protein kinase kinase) inhibition in an autochthonous tumor setting. Our data suggest that lung cancer patients with KRAS-driven disease may benefit from inclusion of multi-ERBB inhibitors in rationally designed treatment strategies.

5 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JMJune Munro
June Munro
SGSarah L Gillen
Sarah L Gillen
LMLouise Mitchell
Louise Mitchell
SLSarah Laing
Sarah Laing
SKSaadia A. Karim
Saadia A. Karim
MBMartin Bushell
Martin Bushell
The protein output of different mRNAs can vary by two orders of magnitude; therefore, it is critical to understand the processes that control gene expression operating at the level of translation. Translatome-wide techniques, such as polysome profiling and ribosome profiling, are key methods for determining the translation rates occurring on specific mRNAs. These techniques are now widely used in cell lines; however, they are underutilised in tissues and cancer models. Ribonuclease (RNase) expression is often found to be higher in complex primary tissues in comparison to cell lines. Methods used to preserve RNA during lysis often use denaturing conditions, which need to be avoided when maintaining the interaction and position of the ribosome with the mRNA is required. Here, we detail the cell lysis conditions that produce high-quality RNA from several different tissues covering a range of endogenous RNase expression levels. We highlight the importance of RNA integrity for accurate determination of the global translation status of the cell as determined by polysome gradients and discuss key aspects to optimise for accurate assessment of the translatome from primary mouse tissue.

6 March 2026 in Science Advances
Verified
Journal Article
Open access
XRXimena L. Raffo-Iraolagoitia
Ximena L. Raffo-Iraolagoitia
AMAmanda J. McFarlane
Amanda J. McFarlane
SLSarah Laing
Sarah Laing
RCRyan Corbyn
Ryan Corbyn
LALindsey W. G. Arnott
Lindsey W. G. Arnott
LCLeo M. Carlin
Leo M. Carlin
γδ T cells are important for host defense at the respiratory mucosa, acting directly or through interactions with other cells. However, how γδ T cells influence other immune cells in the lung remains unclear. Using a genetically engineered mouse model of lung cancer, we show that tumors drive expansion of both CD27 + and CD27 − γδ T cells. Advanced microscopy techniques indicated that CD27 − γδ T cells are enriched in tumors, whereas CD27 + γδ T cells are more prone to interact with macrophages in tumor-associated adventitial cuffs. SiglecF low profibrotic airway macrophages were more prevalent in lung tumor-bearing mice than tumor-free mice. This profibrotic subset was reduced in lungs when the cancer model was crossed to Tcrd knockout mice or treated with Vγ1-depleting antibodies but not in TcrgV4/6 knockout mice. Thus, our findings implicate Vγ1 γδ T cells in driving tumor-associated airway macrophage functional imprinting. Determining the translatability to human health may offer new avenues for refining patient management and immunotherapeutic strategies.


3 April 2023
Verified
Other
Open access
NMNathiya Muthalagu
Nathiya Muthalagu
TMTiziana Monteverde
Tiziana Monteverde
XRXimena Raffo-Iraolagoitia
Ximena Raffo-Iraolagoitia
RWRobert Wiesheu
Robert Wiesheu
DWDeclan Whyte
Declan Whyte
Daniel J. MurphyDaniel J. Murphy
Daniel J. Murphy
Spreadsheet of genes co-regulated by MYC & Miz1 in KMC PDAC cells